Our Product Range
Miyarisan
Miyarisan Pharmaceutical has been contributing to the health of people around the world with the power of the butyric acid bacteria - Clostridium butyricum for more than 80 years.
The Clostridium butyricum Miyairi® 588 (CBM588®) strain was first isolated by Dr Chikaji Miyairi in Japan’s Chiba Medical University in 1933.
Once commercial production began in
1940, it was quickly adopted for use in maintaining gastrointestinal balance
for immune, digestive and bowel movement health.
Social Login